|
Fusion gene ID: 22954 |
FusionGeneSummary for MYCBP2_CPB2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: MYCBP2_CPB2 | Fusion gene ID: 22954 | Hgene | Tgene | Gene symbol | MYCBP2 | CPB2 | Gene ID | 23077 | 1361 |
Gene name | MYC binding protein 2, E3 ubiquitin protein ligase | carboxypeptidase B2 | |
Synonyms | Myc-bp2|PAM|Phr | CPU|PCPB|TAFI | |
Cytomap | 13q22.3 | 13q14.13 | |
Type of gene | protein-coding | protein-coding | |
Description | E3 ubiquitin-protein ligase MYCBP2HighwireRING-type E3 ubiquitin transferase MYCBP2myc-binding protein 2pam/highwire/rpm-1 proteinprotein associated with Myc | carboxypeptidase B2carboxypeptidase B-like proteincarboxypeptidase B2 (plasma)carboxypeptidase B2 (plasma, carboxypeptidase U)carboxypeptidase Rthrombin-activable fibrinolysis inhibitorthrombin-activatable fibrinolysis inhibitor | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | O75592 | Q96IY4 | |
Ensembl transtripts involved in fusion gene | ENST00000544440, ENST00000407578, ENST00000357337, ENST00000360084, ENST00000482517, | ENST00000181383, ENST00000439329, | |
Fusion gene scores | * DoF score | 9 X 9 X 7=567 | 2 X 2 X 2=8 |
# samples | 9 | 2 | |
** MAII score | log2(9/567*10)=-2.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: MYCBP2 [Title/Abstract] AND CPB2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BLCA | TCGA-UY-A78N-01A | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000544440 | ENST00000181383 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
In-frame | ENST00000544440 | ENST00000439329 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
In-frame | ENST00000407578 | ENST00000181383 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
In-frame | ENST00000407578 | ENST00000439329 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
Frame-shift | ENST00000357337 | ENST00000181383 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
Frame-shift | ENST00000357337 | ENST00000439329 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
5UTR-3CDS | ENST00000360084 | ENST00000181383 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
5UTR-3CDS | ENST00000360084 | ENST00000439329 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
intron-3CDS | ENST00000482517 | ENST00000181383 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
intron-3CDS | ENST00000482517 | ENST00000439329 | MYCBP2 | chr13 | 77862296 | - | CPB2 | chr13 | 46638876 | - |
Top |
FusionProtFeatures for MYCBP2_CPB2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
MYCBP2 | CPB2 |
Atypical E3 ubiquitin-protein ligase which specificallymediates ubiquitination of threonine and serine residues on targetproteins, instead of ubiquitinating lysine residues(PubMed:29643511). Shows esterification activity towards boththreonine and serine, with a preference for threonine, and actsvia two essential catalytic cysteine residues that relay ubiquitinto its substrate via thioester intermediates (PubMed:29643511).Interacts with the E2 enzymes UBE2D1, UBE2D3, UBE2E1 and UBE2L3(PubMed:18308511, PubMed:29643511). Plays a key role in neuraldevelopment, probably by mediating ubiquitination of threonineresidues on target proteins (Probable). Involved in differentprocesses such as regulation of neurite outgrowth, synapticgrowth, synaptogenesis and axon degeneration (By similarity).Required for the formation of major central nervous system axontracts (By similarity). Required for proper axon growth byregulating axon navigation and axon branching: acts by regulatingthe subcellular location and stability of MAP3K12/DLK (Bysimilarity). Required for proper localization of retinogeniculateprojections but not for eye-specific segregation (By similarity).Regulates axon guidance in the olfactory system (By similarity).Involved in Wallerian axon degeneration, an evolutionarilyconserved process that drives the loss of damaged axons: acts bypromoting destabilization of NMNAT2, probably via ubiquitinationof NMNAT2 (By similarity). Catalyzes ubiquitination of threonineand/or serine residues on NMNAT2, consequences of threonine and/orserine ubiquitination are however unknown (PubMed:29643511).Regulates the internalization of TRPV1 in peripheral sensoryneurons (By similarity). May mediate ubiquitination and subsequentproteasomal degradation of TSC2/tuberin (PubMed:18308511).Independently of the E3 ubiquitin-protein ligase activity, alsoacts as a guanosine exchange factor (GEF) for RAN in neurons ofdorsal root ganglia (PubMed:26304119). May function as afacilitator or regulator of transcriptional activation by MYC(PubMed:9689053). {ECO:0000250|UniProtKB:Q7TPH6,ECO:0000269|PubMed:18308511, ECO:0000269|PubMed:26304119,ECO:0000269|PubMed:29643511, ECO:0000269|PubMed:9689053}. | Cleaves C-terminal arginine or lysine residues frombiologically active peptides such as kinins or anaphylatoxins inthe circulation thereby regulating their activities. Down-regulates fibrinolysis by removing C-terminal lysine residues fromfibrin that has already been partially degraded by plasmin.{ECO:0000269|PubMed:10574983}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 103_126 | 160 | 4641 | Compositional bias | Lys-rich |
Hgene | MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 103_126 | 160 | 4641 | Compositional bias | Lys-rich |
Tgene | >CPB2 | chr13:77862296 | chr13:46638876 | ENST00000181383 | - | 6 | 11 | 256_257 | 234 | 424 | Region | Substrate binding |
Tgene | >CPB2 | chr13:77862296 | chr13:46638876 | ENST00000181383 | - | 6 | 11 | 311_312 | 234 | 424 | Region | Substrate binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 2720_2844 | 160 | 4641 | Compositional bias | Ser-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 3194_3215 | 160 | 4641 | Compositional bias | Lys-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 3262_3293 | 160 | 4641 | Compositional bias | Note=Gly-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 766_814 | 160 | 4641 | Compositional bias | Cys-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 2720_2844 | 160 | 4641 | Compositional bias | Ser-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 3194_3215 | 160 | 4641 | Compositional bias | Lys-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 3262_3293 | 160 | 4641 | Compositional bias | Note=Gly-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 766_814 | 160 | 4641 | Compositional bias | Cys-rich |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 2466_2535 | 160 | 4641 | Domain | SH3b |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 3719_3897 | 160 | 4641 | Domain | DOC |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 2466_2535 | 160 | 4641 | Domain | SH3b |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 3719_3897 | 160 | 4641 | Domain | DOC |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 1235_1386 | 160 | 4641 | Region | PHR domain 1 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 1726_1884 | 160 | 4641 | Region | PHR domain 2 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 2022_2550 | 160 | 4641 | Region | RAE1 binding |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 4539_4676 | 160 | 4641 | Region | Tandem cysteine domain |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 1235_1386 | 160 | 4641 | Region | PHR domain 1 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 1726_1884 | 160 | 4641 | Region | PHR domain 2 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 2022_2550 | 160 | 4641 | Region | RAE1 binding |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 4539_4676 | 160 | 4641 | Region | Tandem cysteine domain |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 1010_1066 | 160 | 4641 | Repeat | RCC1 5 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 2341_2443 | 160 | 4641 | Repeat | Filamin |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 600_655 | 160 | 4641 | Repeat | RCC1 1 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 699_755 | 160 | 4641 | Repeat | RCC1 2 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 907_957 | 160 | 4641 | Repeat | RCC1 3 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 958_1008 | 160 | 4641 | Repeat | RCC1 4 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 1010_1066 | 160 | 4641 | Repeat | RCC1 5 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 2341_2443 | 160 | 4641 | Repeat | Filamin |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 600_655 | 160 | 4641 | Repeat | RCC1 1 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 699_755 | 160 | 4641 | Repeat | RCC1 2 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 907_957 | 160 | 4641 | Repeat | RCC1 3 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 958_1008 | 160 | 4641 | Repeat | RCC1 4 |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 4428_4479 | 160 | 4641 | Zinc finger | RING-type%3B atypical |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000357337 | - | 4 | 84 | 4582_4632 | 160 | 4641 | Zinc finger | Note=B box-type |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 4428_4479 | 160 | 4641 | Zinc finger | RING-type%3B atypical |
Hgene | >MYCBP2 | chr13:77862296 | chr13:46638876 | ENST00000544440 | - | 3 | 83 | 4582_4632 | 160 | 4641 | Zinc finger | Note=B box-type |
Tgene | CPB2 | chr13:77862296 | chr13:46638876 | ENST00000181383 | - | 6 | 11 | 181_184 | 234 | 424 | Region | Substrate binding |
Top |
FusionGeneSequence for MYCBP2_CPB2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_MYCBP2_ENST00000544440_chr13_77862296_-_CPB2_ENST00000181383_chr13_46638876_-_350aa MPVPDGSVAAAGLGLGLPAADSRGHYQLLLSGRALADRYRRIYTAALNDRDQGGGSAGHPASRNKKILNKKKLKRKQKSKSKVKTRSKSE NLENTVIIPDIKLHSNPSAFNIYCNVRHCVLEWQKKEISLAAASKNSVQSGESDSDEEEESKEPPIKLPKNRMWRKNRSFYANNHCIGTD LNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAI >In-frame_MYCBP2_ENST00000544440_chr13_77862296_-_CPB2_ENST00000439329_chr13_46638876_-_324aa MPVPDGSVAAAGLGLGLPAADSRGHYQLLLSGRALADRYRRIYTAALNDRDQGGGSAGHPASRNKKILNKKKLKRKQKSKSKVKTRSKSE NLENTVIIPDIKLHSNPSAFNIYCNVRHCVLEWQKKEISLAAASKNSVQSGESDSDEEEESKEPPIKLPKNRMWRKNRSFYANNHCIGTD LNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAI >In-frame_MYCBP2_ENST00000407578_chr13_77862296_-_CPB2_ENST00000181383_chr13_46638876_-_388aa MMMCAATASPAAASSGLGGDGFYPAATFSSSPAPGALFMPVPDGSVAAAGLGLGLPAADSRGHYQLLLSGRALADRYRRIYTAALNDRDQ GGGSAGHPASRNKKILNKKKLKRKQKSKSKVKTRSKSENLENTVIIPDIKLHSNPSAFNIYCNVRHCVLEWQKKEISLAAASKNSVQSGE SDSDEEEESKEPPIKLPKNRMWRKNRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAY ISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKISKNTRYTHGHGSETLYLAPGGGDDWIYDLGIKYSFTIELRDTGTYGFLL >In-frame_MYCBP2_ENST00000407578_chr13_77862296_-_CPB2_ENST00000439329_chr13_46638876_-_362aa MMMCAATASPAAASSGLGGDGFYPAATFSSSPAPGALFMPVPDGSVAAAGLGLGLPAADSRGHYQLLLSGRALADRYRRIYTAALNDRDQ GGGSAGHPASRNKKILNKKKLKRKQKSKSKVKTRSKSENLENTVIIPDIKLHSNPSAFNIYCNVRHCVLEWQKKEISLAAASKNSVQSGE SDSDEEEESKEPPIKLPKNRMWRKNRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAY ISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKISKNTRYTHGHGSETLYLAPGGGDDWIYDLGIKYSVTSNPPVEKLLPLSL |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_MYCBP2_ENST00000544440_chr13_77862296_-_CPB2_ENST00000181383_chr13_46638876_-_1050nt ATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCCCGGGGTCACTACCAGCTGCTGCTG TCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAGGGGGGCGGCAGCGCTGGACACCCA GCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAAGTGAAGACAAGAAGCAAGTCTGAA AACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATTTACTGTAATGTACGCCATTGCGTT CTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAATCAGATAGTGATGAAGAAGAGGAA TCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCGAACAATCATTGCATCGGAACAGAC CTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAAACCTACTGTGGACTTTATCCTGAG TCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATACATCAGCATGCATTCATACTCCCAG CATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTAGCCAGTGAAGCAGTTCGTGCTATT GAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCTGGAGGTGGGGACGATTGGATCTAT GATTTGGGCATCAAATATTCGTTTACAATTGAACTTCGAGATACGGGCACATACGGATTCTTGCTGCCGGAGCGTTACATCAAACCCACC >In-frame_MYCBP2_ENST00000544440_chr13_77862296_-_CPB2_ENST00000439329_chr13_46638876_-_972nt ATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCCCGGGGTCACTACCAGCTGCTGCTG TCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAGGGGGGCGGCAGCGCTGGACACCCA GCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAAGTGAAGACAAGAAGCAAGTCTGAA AACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATTTACTGTAATGTACGCCATTGCGTT CTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAATCAGATAGTGATGAAGAAGAGGAA TCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCGAACAATCATTGCATCGGAACAGAC CTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAAACCTACTGTGGACTTTATCCTGAG TCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATACATCAGCATGCATTCATACTCCCAG CATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTAGCCAGTGAAGCAGTTCGTGCTATT GAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCTGGAGGTGGGGACGATTGGATCTAT >In-frame_MYCBP2_ENST00000407578_chr13_77862296_-_CPB2_ENST00000181383_chr13_46638876_-_1164nt ATGATGATGTGCGCAGCGACTGCCTCCCCCGCCGCCGCCTCCTCGGGGCTCGGCGGGGACGGATTCTACCCAGCCGCCACCTTCTCTTCC TCCCCGGCGCCGGGGGCGCTGTTCATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCC CGGGGTCACTACCAGCTGCTGCTGTCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAG GGGGGCGGCAGCGCTGGACACCCAGCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAA GTGAAGACAAGAAGCAAGTCTGAAAACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATT TACTGTAATGTACGCCATTGCGTTCTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAA TCAGATAGTGATGAAGAAGAGGAATCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCG AACAATCATTGCATCGGAACAGACCTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAA ACCTACTGTGGACTTTATCCTGAGTCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATAC ATCAGCATGCATTCATACTCCCAGCATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTA GCCAGTGAAGCAGTTCGTGCTATTGAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCT GGAGGTGGGGACGATTGGATCTATGATTTGGGCATCAAATATTCGTTTACAATTGAACTTCGAGATACGGGCACATACGGATTCTTGCTG >In-frame_MYCBP2_ENST00000407578_chr13_77862296_-_CPB2_ENST00000439329_chr13_46638876_-_1086nt ATGATGATGTGCGCAGCGACTGCCTCCCCCGCCGCCGCCTCCTCGGGGCTCGGCGGGGACGGATTCTACCCAGCCGCCACCTTCTCTTCC TCCCCGGCGCCGGGGGCGCTGTTCATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCC CGGGGTCACTACCAGCTGCTGCTGTCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAG GGGGGCGGCAGCGCTGGACACCCAGCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAA GTGAAGACAAGAAGCAAGTCTGAAAACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATT TACTGTAATGTACGCCATTGCGTTCTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAA TCAGATAGTGATGAAGAAGAGGAATCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCG AACAATCATTGCATCGGAACAGACCTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAA ACCTACTGTGGACTTTATCCTGAGTCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATAC ATCAGCATGCATTCATACTCCCAGCATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTA GCCAGTGAAGCAGTTCGTGCTATTGAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCT GGAGGTGGGGACGATTGGATCTATGATTTGGGCATCAAATATTCCGTTACATCAAACCCACCTGTAGAGAAGCTTTTGCCGCTGTCTCTA |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_MYCBP2_ENST00000544440_chr13_77862296_-_CPB2_ENST00000181383_chr13_46638876_-_1496nt GCGCCGGGGGCGCTGTTCATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCCCGGGGT CACTACCAGCTGCTGCTGTCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAGGGGGGC GGCAGCGCTGGACACCCAGCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAAGTGAAG ACAAGAAGCAAGTCTGAAAACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATTTACTGT AATGTACGCCATTGCGTTCTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAATCAGAT AGTGATGAAGAAGAGGAATCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCGAACAAT CATTGCATCGGAACAGACCTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAAACCTAC TGTGGACTTTATCCTGAGTCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATACATCAGC ATGCATTCATACTCCCAGCATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTAGCCAGT GAAGCAGTTCGTGCTATTGAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCTGGAGGT GGGGACGATTGGATCTATGATTTGGGCATCAAATATTCGTTTACAATTGAACTTCGAGATACGGGCACATACGGATTCTTGCTGCCGGAG CGTTACATCAAACCCACCTGTAGAGAAGCTTTTGCCGCTGTCTCTAAAATAGCTTGGCATGTCATTAGGAATGTTTAATGCCCCTGATTT TATCATTCTGCTTCCGTATTTTAATTTACTGATTCCAGCAAGACCAAATCATTGTATCAAATTATTTTTAAGTTTTATCCGTAGTTTTGA TAAAAGATTTTCCTATTCCTTGGTTCTGTCAGAGAACCTAATAAGTGCTACTTTGCCATTAAGGCAGACTAGGGTTCATGTCTTTTTACC CTTTAAAAAAAATTGTAAAAGTCTAGTTACCTACTTTTTCTTTGATTTTCGACGTTTGACTAGCCATCTCAAGCAAGTTTCGACGTTTGA CTAGCCATCTCAAGCAAGTTTAATCAATGATCATCTCACGCTGATCATTGGATCCTACTCAACAAAAGGAAGGGTGGTCAGAAGTACATT >In-frame_MYCBP2_ENST00000544440_chr13_77862296_-_CPB2_ENST00000439329_chr13_46638876_-_1443nt GCGCCGGGGGCGCTGTTCATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCCCGGGGT CACTACCAGCTGCTGCTGTCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAGGGGGGC GGCAGCGCTGGACACCCAGCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAAGTGAAG ACAAGAAGCAAGTCTGAAAACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATTTACTGT AATGTACGCCATTGCGTTCTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAATCAGAT AGTGATGAAGAAGAGGAATCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCGAACAAT CATTGCATCGGAACAGACCTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAAACCTAC TGTGGACTTTATCCTGAGTCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATACATCAGC ATGCATTCATACTCCCAGCATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTAGCCAGT GAAGCAGTTCGTGCTATTGAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCTGGAGGT GGGGACGATTGGATCTATGATTTGGGCATCAAATATTCCGTTACATCAAACCCACCTGTAGAGAAGCTTTTGCCGCTGTCTCTAAAATAG CTTGGCATGTCATTAGGAATGTTTAATGCCCCTGATTTTATCATTCTGCTTCCGTATTTTAATTTACTGATTCCAGCAAGACCAAATCAT TGTATCAAATTATTTTTAAGTTTTATCCGTAGTTTTGATAAAAGATTTTCCTATTCCTTGGTTCTGTCAGAGAACCTAATAAGTGCTACT TTGCCATTAAGGCAGACTAGGGTTCATGTCTTTTTACCCTTTAAAAAAAATTGTAAAAGTCTAGTTACCTACTTTTTCTTTGATTTTCGA CGTTTGACTAGCCATCTCAAGCAAGTTTCGACGTTTGACTAGCCATCTCAAGCAAGTTTAATCAATGATCATCTCACGCTGATCATTGGA TCCTACTCAACAAAAGGAAGGGTGGTCAGAAGTACATTAAAGATTTCTGCTCCAAATTTTCAATAAATTTCTGCTTGTGCCTTTAGAAAT >In-frame_MYCBP2_ENST00000407578_chr13_77862296_-_CPB2_ENST00000181383_chr13_46638876_-_1859nt CGGCGGCAGTGGCGGCACCGCCTCCTCCTCACATTCCCGGGGTGGCGGGGTTAGATGAGCGGCCCCAGTAGCGGCGAGGGCGGCGCGGGG GGGAGGAGGAGAAGAAGGAGGAGGAGAAGGAGGTCGCTGTCTTTGTAGTCTCCCTGCTGCGGGAGCCAGAGGCCGCCGCCGGAGCCGTCG TCGTTGGAAAAGGGCTGTGTGTGCGCGCGCGTGTCTGCCCGCCCGGCCCGCGGGGACGAGGCGGCGGCGGCGGCGGCGGCGGCGAGGATG ATGATGTGCGCAGCGACTGCCTCCCCCGCCGCCGCCTCCTCGGGGCTCGGCGGGGACGGATTCTACCCAGCCGCCACCTTCTCTTCCTCC CCGGCGCCGGGGGCGCTGTTCATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCCCGG GGTCACTACCAGCTGCTGCTGTCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAGGGG GGCGGCAGCGCTGGACACCCAGCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAAGTG AAGACAAGAAGCAAGTCTGAAAACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATTTAC TGTAATGTACGCCATTGCGTTCTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAATCA GATAGTGATGAAGAAGAGGAATCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCGAAC AATCATTGCATCGGAACAGACCTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAAACC TACTGTGGACTTTATCCTGAGTCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATACATC AGCATGCATTCATACTCCCAGCATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTAGCC AGTGAAGCAGTTCGTGCTATTGAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCTGGA GGTGGGGACGATTGGATCTATGATTTGGGCATCAAATATTCGTTTACAATTGAACTTCGAGATACGGGCACATACGGATTCTTGCTGCCG GAGCGTTACATCAAACCCACCTGTAGAGAAGCTTTTGCCGCTGTCTCTAAAATAGCTTGGCATGTCATTAGGAATGTTTAATGCCCCTGA TTTTATCATTCTGCTTCCGTATTTTAATTTACTGATTCCAGCAAGACCAAATCATTGTATCAAATTATTTTTAAGTTTTATCCGTAGTTT TGATAAAAGATTTTCCTATTCCTTGGTTCTGTCAGAGAACCTAATAAGTGCTACTTTGCCATTAAGGCAGACTAGGGTTCATGTCTTTTT ACCCTTTAAAAAAAATTGTAAAAGTCTAGTTACCTACTTTTTCTTTGATTTTCGACGTTTGACTAGCCATCTCAAGCAAGTTTCGACGTT TGACTAGCCATCTCAAGCAAGTTTAATCAATGATCATCTCACGCTGATCATTGGATCCTACTCAACAAAAGGAAGGGTGGTCAGAAGTAC >In-frame_MYCBP2_ENST00000407578_chr13_77862296_-_CPB2_ENST00000439329_chr13_46638876_-_1806nt CGGCGGCAGTGGCGGCACCGCCTCCTCCTCACATTCCCGGGGTGGCGGGGTTAGATGAGCGGCCCCAGTAGCGGCGAGGGCGGCGCGGGG GGGAGGAGGAGAAGAAGGAGGAGGAGAAGGAGGTCGCTGTCTTTGTAGTCTCCCTGCTGCGGGAGCCAGAGGCCGCCGCCGGAGCCGTCG TCGTTGGAAAAGGGCTGTGTGTGCGCGCGCGTGTCTGCCCGCCCGGCCCGCGGGGACGAGGCGGCGGCGGCGGCGGCGGCGGCGAGGATG ATGATGTGCGCAGCGACTGCCTCCCCCGCCGCCGCCTCCTCGGGGCTCGGCGGGGACGGATTCTACCCAGCCGCCACCTTCTCTTCCTCC CCGGCGCCGGGGGCGCTGTTCATGCCGGTTCCCGACGGCTCCGTGGCTGCTGCGGGGCTGGGGCTGGGGCTACCCGCCGCGGACTCCCGG GGTCACTACCAGCTGCTGCTGTCAGGCCGGGCCCTGGCCGACCGCTACCGGAGGATTTATACCGCTGCGCTCAATGACAGGGACCAGGGG GGCGGCAGCGCTGGACACCCAGCCTCCAGGAATAAGAAAATTTTAAATAAGAAGAAATTGAAAAGAAAACAGAAGAGCAAATCAAAAGTG AAGACAAGAAGCAAGTCTGAAAACTTAGAGAATACAGTAATCATACCAGATATCAAACTACATAGCAATCCTTCTGCTTTCAATATTTAC TGTAATGTACGCCATTGCGTTCTGGAATGGCAGAAAAAGGAAATATCATTGGCAGCCGCATCTAAGAACTCTGTGCAGAGTGGAGAATCA GATAGTGATGAAGAAGAGGAATCCAAAGAGCCCCCTATCAAGCTTCCAAAGAATCGAATGTGGAGAAAGAACCGTTCTTTCTATGCGAAC AATCATTGCATCGGAACAGACCTGAATAGGAACTTTGCTTCCAAACACTGGTGTGAGGAAGGTGCATCCAGTTCCTCATGCTCGGAAACC TACTGTGGACTTTATCCTGAGTCAGAACCAGAAGTGAAGGCAGTGGCTAGTTTCTTGAGAAGAAATATCAACCAGATTAAAGCATACATC AGCATGCATTCATACTCCCAGCATATAGTGTTTCCATATTCCTATACACGAAGTAAAAGCAAAGACCATGAGGAACTGTCTCTAGTAGCC AGTGAAGCAGTTCGTGCTATTGAGAAAATTAGTAAAAATACCAGGTATACACATGGCCATGGCTCAGAAACCTTATACCTAGCTCCTGGA GGTGGGGACGATTGGATCTATGATTTGGGCATCAAATATTCCGTTACATCAAACCCACCTGTAGAGAAGCTTTTGCCGCTGTCTCTAAAA TAGCTTGGCATGTCATTAGGAATGTTTAATGCCCCTGATTTTATCATTCTGCTTCCGTATTTTAATTTACTGATTCCAGCAAGACCAAAT CATTGTATCAAATTATTTTTAAGTTTTATCCGTAGTTTTGATAAAAGATTTTCCTATTCCTTGGTTCTGTCAGAGAACCTAATAAGTGCT ACTTTGCCATTAAGGCAGACTAGGGTTCATGTCTTTTTACCCTTTAAAAAAAATTGTAAAAGTCTAGTTACCTACTTTTTCTTTGATTTT CGACGTTTGACTAGCCATCTCAAGCAAGTTTCGACGTTTGACTAGCCATCTCAAGCAAGTTTAATCAATGATCATCTCACGCTGATCATT GGATCCTACTCAACAAAAGGAAGGGTGGTCAGAAGTACATTAAAGATTTCTGCTCCAAATTTTCAATAAATTTCTGCTTGTGCCTTTAGA |
Top |
FusionGenePPI for MYCBP2_CPB2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MYCBP2 | BAK1, SFN, MYC, USP11, RAE1, WDR48, NR1D1, UBC, UBE3A, YWHAB, YWHAG, CALM1, SIRT7, FBXO45, CUL4B, ATP13A2, YWHAQ, NOS2, CBX2, CBX4, ROBO2, HDAC11, LGR4, CCDC8, CCDC158, TDGF1, SESN3, DEF6, SKAP1, CLEC11A, CASQ2, LILRA3, ALDH1L2, WHSC1, PLK4, MED4, SRPK2, LGALS3BP, YWHAH, YWHAZ, SLAIN2, VPS26B, SKA1, HEY1, CRY1, CRY2, FBXW7, MEX3C, FAF1, ATOH1, CDC14A, STAT2, DOCK5, CETN1, TXNIP, CDH19, CCDC65, GUCY1B3, GDF10, PAPL, MYLIP, PGBD1, PDGFB, CTNNA3, PCDHA3, NEURL4 | CPB2 | A2M, F2, PLG, C5, FN1, TINAG |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MYCBP2_CPB2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MYCBP2_CPB2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | CPB2 | C0002453 | Amenorrhea | 1 | CTD_human |
Tgene | CPB2 | C0028754 | Obesity | 1 | CTD_human |